Message from the President
The ISSCR submitted comments to Brazil’s health regulatory agency (ANVISA) regarding the proposed regulations for advanced therapy medicinal products that urge national governments to “maintain rigorous review pathways to ensure that stem cell-based products conform to the highest standards of evidence-based medicine.”Full story
- 10 October, 2019
Polices created by legislators and regulators can have a profound impact on stem cell and biomedical research and the development of new treatments. The ISSCR has been working on several fronts to advocate for responsible stem cell research and its application. Read more about the recent ISSCR-led fly in to Washington D.C. for discussions with government officials and our consultations with Google to prevent the marketing of unproven stem cell therapies.Full story
- 7 October, 2019
Gladstone Institutes, U.S.
The ISSCR Annual Meetings are the largest stem cell conferences in the world, known for featuring outstanding science. However, an underrecognized yet equally important aspect of the society is its initiatives to advance the field. Read more about how the ISSCR is working to develop guidelines and standards for the field, advocate for responsible stem cell policies, provide resources for career development, public outreach, and patient education, and help researchers excel in their science and advance the clinical translation of stem cell research.
Communicating About Unproven Stem Cell Treatments to the Public
Stem Cells in the News
Media highlights in the field of stem cell research and its translation to the clinic.
8 August, Stem Cell Xpress
CRISPR Gene Editing Is Being Tested in Human Patients, and the Results Could Revolutionize Health Care
6 August, Time
3 August, The Guardian
A sampling of recent stem cell research commentaries, articles, and resources.
On the cover: Cover In this issue, Karch et al. describe a resource of patient-derived fibroblasts and induced pluripotent stem cells with comprehensive clinical histories for modeling primary tauopathies. Sagittal view of a Magnetic Resonance Imaging (MRI) brain scan shows pronounced frontoinsular atrophy in a patient with behavioral variant-frontotemporal dementia (FTD). The brain image is overlaid with a human induced pluripotent stem cell culture described in Karch et al. that has been differentiated into cortical neurons. Neurons are stained with the nuclear marker DAPI (blue), and the neuronal marker TujI (green). Images were provided by Stephanie Chu, Suzee Lee, Aimee Kao, Sally Temple, Rita Martinez, and Celeste Karch.
Featured Current Protocols in Stem Cell Biology Article
A High-Throughput Screening Method to Identify Compounds Displaying Human Vascular Embryonic Toxicity, Rose et al. (2019), Current Protocols in Stem Cell Biology, 50, e93. doi: 10.1002/cpsc.93.
Induced 2C Expression and Implantation-Competent Blastocyst-Like Cysts From Primed Pluripotent Stem Cells, Kime et al (2019), Stem Cell Reports. doi:10.1016/j.stemcr.2019.07.011.
- , Shanghai
Seeking a job? Have a job opening? the ISSCR Job Board gives members discounts on job postings here and in the monthly Pulse e-newsletter.
Other Stem Cell Events
Opportunities for researchers from around the world to explore the latest discoveries in stem cell science and regenerative medicine.
Global Policy News
ISSCR and policy news from around the world.
25 July, Regulatory Focus
As Stem Cell Clinics Proliferate, Energy and Commerce Leaders Seek to Hear FDA’s Plan
26 July, Science
Trump Administration Releases Details on Fetal Tissue Restrictions
3 August, The Guardian
FDA First Human-Monkey Chimera Raises Concern Among Scientists
Learn about ISSCR colleagues in the stem cell field from around the world.
Zubin Master, PhD
Saint Paul, Minnesota, USA
PhD, University of Toronto, Canada
Associate Professor of Biomedical Ethics, Mayo Clinic, MN, USA